SRAX (SRAX) Stock Forecast, Price Target & Predictions


OverviewOwnershipChart

SRAX Stock Forecast


SRAX stock forecast is as follows: an average price target of $6.00 (represents a 8471.43% upside from SRAX’s last price of $0.07) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

SRAX Price Target


The average price target for SRAX (SRAX) is $6.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $6.00. This represents a potential 8471.43% upside from SRAX's last price of $0.07.

SRAX Analyst Ratings


Buy

According to 2 Wall Street analysts, SRAX's rating consensus is 'Buy'. The analyst rating breakdown for SRAX stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

SRAX Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 26, 2022Raymond James--206.12%8471.43%
Row per page
Go to

The latest SRAX stock forecast, released on Sep 26, 2022 by Raymond James company, set a price target of $6.00, which represents a 206.12% increase from the stock price at the time of the forecast ($1.96), and a 8471.43% increase from SRAX last price ($0.07).

SRAX Price Target by Period


1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.07$0.07$0.07
Upside/Downside-100.00%-100.00%-100.00%

In the current month, the average price target of SRAX stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to SRAX's last price of $0.07. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Jan 13, 2023B. Riley SecuritiesBuyBuyHold
Sep 26, 2022Dawson JamesBuyBuyHold
Row per page
Go to

SRAX's last stock rating was published by B. Riley Securities on Jan 13, 2023. The company gave SRAX a "Buy" rating, the same as its previous rate.

SRAX Financial Forecast


SRAX Revenue Forecast

Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Dec 19Sep 19Jun 19Mar 17Mar 16Sep 15
Revenue----------$7.50M$9.59M$8.31M$7.68M$5.44M$4.52M$2.61M$1.17M$1.09M$1.00M$904.22K$5.33M$5.47M$7.39M
Avg Forecast$12.15M$11.30M$6.02M$10.34M$9.75M$9.84M$9.39M$8.11M$10.80M$11.34M$11.40M$9.92M$8.12M$6.95M$5.68M$4.36M$1.74M$700.00K$6.00M$5.00M$5.00M$2.67M$683.75K$14.78M
High Forecast$12.15M$11.30M$7.22M$10.34M$9.75M$9.84M$9.39M$8.11M$10.80M$11.34M$11.40M$9.92M$8.12M$6.95M$5.68M$4.36M$1.74M$700.00K$6.00M$5.00M$5.00M$3.20M$820.50K$17.74M
Low Forecast$12.15M$11.30M$4.82M$10.34M$9.75M$9.84M$9.39M$8.11M$10.80M$11.34M$11.40M$9.92M$8.12M$6.95M$5.68M$4.36M$1.74M$700.00K$6.00M$5.00M$5.00M$2.13M$547.00K$11.82M
# Analysts991911159981111111111115121815
Surprise %----------0.66%0.97%1.02%1.10%0.96%1.04%1.50%1.66%0.18%0.20%0.18%2.00%8.00%0.50%

SRAX's average Quarter revenue forecast for Jun 22 based on 1 analysts is $11.34M, with a low forecast of $11.34M, and a high forecast of $11.34M. SRAX's average Quarter revenue forecast represents a 51.18% increase compared to the company's last Quarter revenue of $7.50M (Mar 22).

SRAX EBITDA Forecast

Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Dec 19Sep 19Jun 19Mar 17Mar 16Sep 15
# Analysts991911159981111111111115121815
EBITDA----------$-1.01M$615.00K$43.00K$-689.00K$-1.01M$7.37M$-2.94M$-3.32M$-3.69M$1.82M$-7.64M$-1.20M$-1.42M$-1.47M
Avg Forecast$-1.95M$-1.82M$-967.08K$-1.66M$-1.57M$-1.58M$-1.51M$-899.18K$-5.85M$-6.14M$-6.18M$-5.37M$-4.40M$-3.76M$-3.08M$-2.36M$-942.09K$-1.97M$-3.25M$-2.71M$-12.13M$-1.32M$-7.65M$-626.94K
High Forecast$-1.95M$-1.82M$-773.66K$-1.66M$-1.57M$-1.58M$-1.51M$-719.34K$-5.85M$-6.14M$-6.18M$-5.37M$-4.40M$-3.76M$-3.08M$-2.36M$-942.09K$-1.57M$-3.25M$-2.71M$-9.71M$-1.06M$-6.12M$-501.55K
Low Forecast$-1.95M$-1.82M$-1.16M$-1.66M$-1.57M$-1.58M$-1.51M$-1.08M$-5.85M$-6.14M$-6.18M$-5.37M$-4.40M$-3.76M$-3.08M$-2.36M$-942.09K$-2.36M$-3.25M$-2.71M$-14.56M$-1.59M$-9.18M$-752.33K
Surprise %----------0.16%-0.11%-0.01%0.18%0.33%-3.12%3.12%1.69%1.14%-0.67%0.63%0.91%0.19%2.34%

1 analysts predict SRAX's average Quarter EBITDA for Mar 22 to be $-6.18M, with a high of $-6.18M and a low of $-6.18M. This is -1104.24% lower than SRAX's previous annual EBITDA (Dec 21) of $615.00K.

SRAX Net Income Forecast

Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Dec 19Sep 19Jun 19Mar 17Mar 16Sep 15
# Analysts991911159981111111111115121815
Net Income----------$3.73M$610.00K$-3.83M$-10.57M$-7.45M$190.00K$-6.57M$-5.32M$-4.38M$1.41M$-8.10M$-2.03M$-2.40M$-658.54K
Avg Forecast$40.50M$35.25M$-52.94M$682.25K$900.88K$1.09M$-48.13M$-1.61M$526.83K$1.05M$-43.75M$49.83M$-10.30K$2.86M$-39.77M$-1.29M$-8.17M$-3.15M$-3.95M$-4.48M$-12.86M$-2.23M$-12.97M$-889.03K
High Forecast$40.50M$35.25M$-42.35M$682.25K$900.88K$1.09M$-38.50M$-1.29M$526.83K$1.05M$-35.00M$49.83M$-10.30K$2.86M$-31.82M$-1.29M$-8.17M$-2.52M$-3.95M$-4.48M$-10.29M$-1.78M$-10.38M$-711.22K
Low Forecast$40.50M$35.25M$-63.53M$682.25K$900.88K$1.09M$-57.75M$-1.94M$526.83K$1.05M$-52.50M$49.83M$-10.30K$2.86M$-47.73M$-1.29M$-8.17M$-3.78M$-3.95M$-4.48M$-15.44M$-2.67M$-15.56M$-1.07M
Surprise %-----------0.09%0.01%371.78%-3.70%0.19%-0.15%0.80%1.69%1.11%-0.31%0.63%0.91%0.19%0.74%

SRAX's average Quarter net income forecast for Jun 22 is $1.05M, with a range of $1.05M to $1.05M. SRAX's average Quarter net income forecast represents a -71.74% decrease compared to the company's last Quarter net income of $3.73M (Mar 22).

SRAX SG&A Forecast

Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Dec 19Sep 19Jun 19Mar 17Mar 16Sep 15
# Analysts991911159981111111111115121815
SG&A----------$5.84M$6.87M$7.74M$6.92M$4.83M$4.98M$3.87M$3.70M$3.60M$5.39M$5.11M$4.41M$3.81M$3.75M
Avg Forecast$24.61M$22.90M$12.20M$20.95M$19.76M$19.94M$19.04M$6.68M$21.89M$22.97M$23.10M$20.09M$16.46M$14.08M$11.52M$8.84M$3.52M$1.42M$12.16M$10.13M$10.13M$5.40M$1.39M$5.06M
High Forecast$24.61M$22.90M$14.64M$20.95M$19.76M$19.94M$19.04M$8.01M$21.89M$22.97M$23.10M$20.09M$16.46M$14.08M$11.52M$8.84M$3.52M$1.42M$12.16M$10.13M$10.13M$6.48M$1.66M$6.08M
Low Forecast$24.61M$22.90M$9.76M$20.95M$19.76M$19.94M$19.04M$5.34M$21.89M$22.97M$23.10M$20.09M$16.46M$14.08M$11.52M$8.84M$3.52M$1.42M$12.16M$10.13M$10.13M$4.32M$1.11M$4.05M
Surprise %----------0.25%0.34%0.47%0.49%0.42%0.56%1.10%2.61%0.30%0.53%0.50%0.82%2.75%0.74%

SRAX's average Quarter SG&A projection for Jun 22 is $22.97M, based on 1 Wall Street analysts, with a range of $22.97M to $22.97M. The forecast indicates a 293.25% rise compared to SRAX last annual SG&A of $5.84M (Mar 22).

SRAX EPS Forecast

Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Dec 19Sep 19Jun 19Mar 17Mar 16Sep 15
# Analysts991911159981111111111115121815
EPS----------$0.14$0.02$-0.30$-0.45$-0.38$0.01$-0.45$-0.38$-0.31$0.11$-0.67$-0.26$-0.40$-0.10
Avg Forecast$1.54$1.34$1.57$0.03$0.03$0.04$0.02$0.08$0.02$0.04$0.07$1.89$-0.00$0.11$-0.13$-0.05$-0.31$-0.26$-0.15$-0.17$-0.17$-0.14$-0.27$-0.27
High Forecast$1.54$1.34$1.57$0.03$0.03$0.04$0.02$0.08$0.02$0.04$0.07$1.89$-0.00$0.11$-0.13$-0.05$-0.31$-0.26$-0.15$-0.17$-0.17$-0.11$-0.22$-0.22
Low Forecast$1.54$1.34$1.57$0.03$0.03$0.04$0.02$0.08$0.02$0.04$0.07$1.89$-0.00$0.11$-0.13$-0.05$-0.31$-0.26$-0.15$-0.17$-0.17$-0.17$-0.32$-0.32
Surprise %----------2.00%0.01%767.26%-4.15%3.01%-0.24%1.45%1.46%2.09%-0.65%3.94%1.86%1.48%0.37%

According to 1 Wall Street analysts, SRAX's projected average Quarter EPS for Jun 22 is $0.04, with a low estimate of $0.04 and a high estimate of $0.04. This represents a -71.43% decrease compared to SRAX previous annual EPS of $0.14 (Mar 22).

SRAX Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
SRAXSRAX--8471.43%Buy
DRCTDirect Digital--520.16%Buy
EEXEmerald--56.13%Buy
QNSTQuinStreet--11.87%Buy
ADTHAdTheorent--9.03%Hold
QUOTQuotient---12.50%Hold

SRAX Forecast FAQ


Is SRAX a good buy?

Yes, according to 2 Wall Street analysts, SRAX (SRAX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of SRAX's total ratings.

What is SRAX's price target?

SRAX (SRAX) average price target is $6 with a range of $6 to $6, implying a 8471.43% from its last price of $0.07. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will SRAX stock go up soon?

According to Wall Street analysts' prediction for SRAX stock, the company can go up by 8471.43% (from the last price of $0.07 to the average price target of $6), up by 8471.43% based on the highest stock price target, and up by 8471.43% based on the lowest stock price target.

Can SRAX stock reach $0?

SRAX's average twelve months analyst stock price target of $6 supports the claim that SRAX can reach $0 in the near future.

What are SRAX's analysts' financial forecasts?

SRAX's analysts financial forecasts for the fiscal year (Dec 2022) are as follows: average revenue is $41.66M (high $41.66M, low $41.66M), average EBITDA is $-19.07M (high $-18.89M, low $-19.249M), average net income is $-43.783M (high $-34.71M, low $-52.856M), average SG&A $74.65M (high $75.99M, low $73.32M), and average EPS is $0.209 (high $0.209, low $0.209). SRAX's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $39.32M (high $39.32M, low $39.32M), average EBITDA is $-6.318M (high $-6.318M, low $-6.318M), average net income is $-45.452M (high $-35.827M, low $-55.077M), average SG&A $79.68M (high $79.68M, low $79.68M), and average EPS is $0.118 (high $0.118, low $0.118).

Did the SRAX's actual financial results beat the analysts' financial forecasts?

Based on SRAX's last annual report (Dec 2021), the company's revenue was $28.55M, which missed the average analysts forecast of $30.67M by -6.91%. Apple's EBITDA was $2.8M, missing the average prediction of $-16.614M by -116.84%. The company's net income was $1.96M, missing the average estimation of $12.9M by -84.85%. Apple's SG&A was $19.46M, missing the average forecast of $62.15M by -68.69%. Lastly, the company's EPS was $-1.48, missing the average prediction of $1.87 by -178.99%. In terms of the last quarterly report (Mar 2022), SRAX's revenue was $7.5M, missing the average analysts' forecast of $11.4M by -34.23%. The company's EBITDA was $-1.013M, missing the average prediction of $-6.176M by -83.60%. SRAX's net income was $3.73M, missing the average estimation of $-43.751M by -108.52%. The company's SG&A was $5.84M, missing the average forecast of $23.1M by -74.71%. Lastly, the company's EPS was $0.14, beating the average prediction of $0.07 by 100.00%